• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista Harnesses New Kinds of Augmented and Artificial Intelligence to Address COVID-19 August 25, 2020
  • Repositioning Safety May 22, 2020
  • Artificial Intelligence firm Biovista repositions four promising therapeutics against COVID-19 April 22, 2020
  • Business Development Agent in Japan February 12, 2020
  • High Throughput Layout and Copy Paste July 5, 2019

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

Immune checkpoint blockade in cancer immunotherapy

August 28, 2018Cancer, Cancer Immunotherapy, Vizit Graphs
Immune checkpoint blockade in cancer immunotherapyChristos Andronis2020-08-03T13:49:12+00:00
Immune checkpoint blockade in cancer immunotherapy

Explore immune checkpoint blockade (PD-1, CTLA-4) in cancer immunotherapy with Biovista Vizit.

Explore the live graph.

Tags: ABATACEPT, CANCER, CTLA4, CYTOKINE PRODUCTION, IMMUNE RESPONSE, IPILIMUMAB, LYMPHOCYTE ACTIVATION, MELANOMA, NIVOLUMAB, PD-1, PEMBROLIZUMAB, PROGRAMMED CELL DEATH, REGULATORY T-LYMPHOCYTES, T CELL ACTIVATION

Post navigation

← Circadian rhythm genes
Drugs for Parkinson’s and Alzheimer’s →

Vizit Graphs Tag Cloud

CD4 COAGULATION IMMUNE RESPONSE INTERFERON INFLAMMATION LISTERIA MONOCYTOGENES MYALGIA IL6 IL10 ANGIOTENSIN II RAS LACTATE DEHYDROGENASE INFLAMMATORY RESPONSE NEUTROPHILS COGNITION PARKINSON DISEASE CANDIDA ALBICANS IMMUNITY NFKB1 TMPRSS2 PSEUDOMONAS AERUGINOSA ACE2 CELL DIFFERENTIATION AUTOPHAGY SARS-COV-2 METFORMIN RHEUMATOID ARTHRITIS IL1B ALZHEIMER'S DISEASE ACE STAPHYLOCOCCUS AUREUS COVID-19 ESCHERICHIA COLI CASP3 HELICOBACTER PYLORI APOPTOTIC PROCESS ALBUMIN INSULIN CANCER CELL PROLIFERATION AGING IL2 TNF PD-1 IFNG

© 2021 Biovista Vizit All Rights Reserved.